Evidence map›Paper›PMID 31209304›Full record

ArticleNature2019

Author Correction: Single-cell transcriptomic analysis of Alzheimer's disease.

Hansruedi Mathys, Jose Davila-Velderrain, Zhuyu Peng, Fan Gao, Shahin Mohammadi, Jennie Z Young, Madhvi Menon, Liang He, Fatema Abdurrob, Xueqiao Jiang and 6 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
  7. Review
  8. Amyloid precursor protein induces reactive astrogliosis.bioRxiv : the preprint server for biology · 2023
    Article
  9. Cystatin F (eLife · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Hansruedi MathysPicower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
Jose Davila-VelderrainMIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA.
Zhuyu PengPicower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
Fan GaoPicower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
Shahin MohammadiMIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA.
Jennie Z YoungPicower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
Madhvi MenonBroad Institute of MIT and Harvard, Cambridge, MA, USA.
Liang HeMIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA.
Fatema AbdurrobPicower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
Xueqiao JiangPicower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
Anthony J MartorellPicower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA.
Richard M RansohoffThird Rock Ventures, Boston, MA, USA.
Brian P HaflerBroad Institute of MIT and Harvard, Cambridge, MA, USA.
David A BennettRush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
Manolis KellisMIT Computer Science and Artificial Intelligence Laboratory, Cambridge, MA, USA. manoli@mit.edu.
Li-Huei TsaiPicower Institute for Learning and Memory, Massachusetts Institute of Technology, Cambridge, MA, USA. lhtsai@mit.edu.

Funding

Cell type specific epigenetic analysis to understand complex mechanisms underlying Alzheimer's disease phenotypesRF1AG054012 · NIA · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI KELLIS, MANOLIS, TSAI, LI-HUEI · 2016 to 2016
$3.9M
Single Cell Transcriptional and Epigenomic Dissection of Schizophrenia and Bipoloar DiseaseU01MH119509 · NIMH · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI KELLIS, MANOLIS · 2019 to 2019
$625k
NIA NIH HHS RF1 AG054012NIMH NIH HHS U01 MH119509
6 · The paper itself

Abstract

Change history: In this Article, the Acknowledgements section should have included that the work was supported in part by the Cure Alzheimer's Fund (CAF), and the final NIH grant acknowledged should have been 'U01MH119509' instead of 'RF1AG054012'. In Supplementary Table 2, the column labels 'early.pathology.mean' and 'late.pathology.mean' were reversed in each worksheet (that is, columns Y and Z). These errors have been corrected online.

Identifiers

PMID31209304
PMCPMC9009526

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.